Michael Wong
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/05/2024
Provenienza dei contatti di primo grado di Michael Wong
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael Wong tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| PEGASYSTEMS INC. | Information Technology Services | Comptroller/Controller/Auditor | |
| VERICEL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
DCF Capital LLC
 DCF Capital LLC Investment ManagersFinance DCF Capital LLC is an independent hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded by Douglas C. Floren and Lance Willsey in 1998. They provide investment advice to high net worth clients. | Investment Managers | Corporate Officer/Principal | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| ATHENEXPAR | Pharmaceuticals: Major | Corporate Officer/Principal | |
Summer Street Research Partners
 Summer Street Research Partners Investment Banks/BrokersFinance Founded in 2002, Summer Street Research Partners is an investment banking and securities firm headquartered in Boston, Massachusetts. The firm is a subsidiary of Northland Securities, Inc. and their ultimate parent is Northland Capital Holdings, Inc. They were formerly known as Custom Equity Research, Inc. Summer Street Research firm focuses on the healthcare sector. | Investment Banks/Brokers | Corporate Officer/Principal | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Graduate Degree Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
| Anderson University | College/University | Doctorate Degree | |
| Bentley University | College/University | Graduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree | |
| James Madison University | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree | |
| Lake Forest College | College/University | Undergraduate Degree | |
| Texas Tech University | College/University | Undergraduate Degree | |
| Plymouth State University | College/University | Undergraduate Degree | |
| Rhode Island College | College/University | Undergraduate Degree | |
| Providence College & Theological Seminary | College/University | Doctorate Degree | |
Discovery Capital Management LLC
 Discovery Capital Management LLC Investment ManagersFinance Discovery Capital Management LLC (Discovery) is a SEC-registered investment advisor and hedge fund manager headquartered in South Norwalk, Connecticut. The firm was founded by Robert Citrone in 1999 and they a subsidiary of Discovery Capital Management Holding Co, LP. Discovery provides discretionary investment advisory services to pooled investment funds intended for institutional and sophisticated investors. | Investment Managers | Analyst-Equity | |
| University of Parma | College/University | Doctorate Degree | |
| Texas Tech University Health Sciences Center | College/University | Graduate Degree | |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Drexel University College of Medicine | College/University | Doctorate Degree | |
ZappRx, Inc.
 ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Chief Operating Officer | |
| The Fuqua School of Business | College/University | Masters Business Admin | |
| The University of Houston Law Center | College/University | Graduate Degree | |
| Sotio LLC | Chief Operating Officer | ||
Vineti, Inc.
 Vineti, Inc. Medical/Nursing ServicesHealth Services Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA. | Medical/Nursing Services | Founder | |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Hogan Lovells LLP
 Hogan Lovells LLP Miscellaneous Commercial ServicesCommercial Services Hogan Lovells LLP provides legal advisory services. The private company is based in Washington. | Miscellaneous Commercial Services | General Counsel | |
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Servier Pharmaceuticals LLC
 Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Lykan Biosciences LLC | Director/Board Member | ||
| BRII BIOSCIENCES LIMITED | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Kuur Therapeutics, Inc. | General Counsel | ||
| Genito Urinary Medical Oncologists of Canada Gumo | Corporate Officer/Principal | ||
Sotio Biotech AS
 Sotio Biotech AS BiotechnologyHealth Technology SOTIO Biotech AS is a company based in Prague, Czechia. The Czech company is focused on developing potent immunotherapies for cancer patients. The company's pipeline includes three clinical-stage programs: SOT102, a next-generation claudin-18.2-targeted antibody-drug conjugate; BOXR1030, a metabolically-enhanced CAR-T cell therapy targeting GPC3-expressing tumors; and SOT201, a next-generation PD-1-targeting immunocytokine. SOTIO Biotech is a member of the PPF Group. Radek Špíšek has been the CEO of the company since 2010. | Biotechnology | Chief Operating Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Canada | 3 |
| Svizzera | 2 |
| Italia | 2 |
| Cina | 2 |
Settori
| Consumer Services | 18 |
| Health Technology | 17 |
| Finance | 5 |
| Commercial Services | 5 |
| Technology Services | 3 |
Posizioni
| Director/Board Member | 45 |
| Corporate Officer/Principal | 37 |
| Independent Dir/Board Member | 18 |
| Chief Tech/Sci/R&D Officer | 12 |
| Undergraduate Degree | 12 |
Contatti più connessi
- Borsa valori
- Insiders
- Michael Wong
- Connessioni Società
